Clinical Trial Detail

NCT ID NCT03768063
Title A Study in Patients Previously Enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd Sponsored Atezolizumab Study (IMbrella B)
Recruitment Recruiting
Gender both
Phase FDA approved
Variant Requirements No
Sponsors Hoffmann-La Roche
Indications

cancer

Therapies

Atezolizumab

Age Groups: adult senior

No variant requirements are available.